Carbinoxamine maleate and Headache - a phase IV clinical study of FDA data

Summary:

Headache is reported as a side effect among people who take Carbinoxamine maleate (carbinoxamine maleate), especially for people who are female, 60+ old, also take Acetaminophen, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Headache when taking Carbinoxamine maleate. It is created by eHealthMe based on reports of 180 people who have side effects when taking Carbinoxamine maleate from the FDA, and is updated regularly.

What is Carbinoxamine maleate?

Carbinoxamine maleate has active ingredients of carbinoxamine maleate. eHealthMe is studying from 183 Carbinoxamine maleate users. Check the latest studies of Carbinoxamine maleate.

What is Headache?

Headache (pain in head) is found to be associated with 3,753 drugs and 5,772 conditions by eHealthMe. Check the latest studies of Headache.

On Jul, 10, 2026

180 people reported to have side effects when taking Carbinoxamine maleate.
Among them, 11 people (6.11%) have Headache.

Could Carbinoxamine maleate cause Headache?

Among these 11 people:

What is the gender of people who have Headache when taking Carbinoxamine maleate? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Headache when taking Carbinoxamine maleate? *

What are other drugs people take besides Carbinoxamine maleate? *

Acetaminophen: 5 people, 45.45%
Simvastatin: 4 people, 36.36%
Gabapentin: 4 people, 36.36%
Zyrtec: 4 people, 36.36%
Epinephrine: 3 people, 27.27%
Hydrochlorothiazide: 3 people, 27.27%
Plaquenil: 3 people, 27.27%
Proair Hfa: 3 people, 27.27%
Flonase Allergy Relief: 3 people, 27.27%
Pantoprazole Sodium: 3 people, 27.27%

What are other side effects people have besides Headache? *

Fatigue (feeling of tiredness): 7 people, 63.64%
Nausea (feeling of having an urge to vomit): 4 people, 36.36%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 4 people, 36.36%
Cough: 4 people, 36.36%
Constipation: 4 people, 36.36%
Fever: 4 people, 36.36%
Pneumonia: 4 people, 36.36%
Upper Respiratory Tract Infection: 4 people, 36.36%
Joint Pain: 4 people, 36.36%
Dyspnea (difficult or laboured breathing): 4 people, 36.36%

What are the existing conditions these people have? *

Asthma: 3 people, 27.27%
Immunodeficiency Common Variable: 3 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
The Flu (the flu is caused by an influenza virus): 2 people, 18.18%
Erection Problems: 1 person, 9.09%
Asthmatic Crisis: 1 person, 9.09%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 9.09%
Constipation: 1 person, 9.09%
Diabetes: 1 person, 9.09%
Drowsiness: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Carbinoxamine maleate and have Headache?

- Check whether Headache is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carbinoxamine maleate:

Carbinoxamine maleate (183 reports)

Headache treatments and more:

Headache (756,642 reports)

Browse all side effects of Carbinoxamine maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Headache:

Headache (3,753 drugs)

Browse all the conditions that are associated with Headache:

Headache (5,772 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carbinoxamine maleate (the active ingredients of Carbinoxamine maleate) and Carbinoxamine maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.